InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2023-11-14 00:00:00 ET · period of report 2023-11-10 · accession 0001209191-23-055220 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-11-14 2023-11-10 HCA Billington Phillip G SVP-Internal Audit Services F - Tax $232.82 -6,237 49.9K -11% -$1.45M
D 2023-11-14 2023-11-10 HCA Billington Phillip G SVP-Internal Audit Services M - OptEx $47.97 +12.0K 56.1K +27% +$576.8K
DM 2023-11-14 2023-11-10 HCA Billington Phillip G SVP-Internal Audit Services M - OptEx $0.00 -12.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-11-10 F D 6,237 $232.82 49,860.45 D — — (F1) Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
2 Common Common Stock 2023-11-10 M A 12,025 $47.97 56,097.45 D — — (F1) Includes 2,283.4544 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
3 Derivative Stock Appreciation Right 2023-11-10 M D 6,500 $0.00 0 D $47.97 · — to 2024-02-05 6,500 Common Stock (F2) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015.
4 Derivative Stock Appreciation Right 2023-11-10 M D 5,525 $0.00 0 D $47.97 · — to 2024-02-05 5,525 Common Stock (F3) The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets.